Lundbeck Ready To Funnel 2022 Growth Into Expected Alzheimer’s Agitation Launch

 
• By Joseph Haas
  
Lundbeck
Lundbeck is getting for an approval in Alzheimer's agitation • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business